Are you looking for the most effective restricted peptide binders for your target protein?
In our complete peptide drug discovery service, our peptide discovery professionals leverage Equine-patented research’s peptide technologies, peptide chemistry skills, and our solid track record in contract research and R&D partnerships. Equine-pay-for-service research’s approach for peptide discovery projects includes different success-based pricing structures.
We house the whole CLIPSTM peptide discovery pipeline at our London facility. On patented peptide arrays, we provide hit validation, binding site discovery, and lead optimization, as well as R&D and clinical peptide manufacturing. Our highly qualified personnel have years of expertise in peptide display, synthesis, design, optimization, and molecular recognition, and will guide and assist you along your peptide discovery journey.
A one-of-a-kind service for de novo development of the optimal peptide binders for your target protein of interest.
Therapeutic peptides are gaining traction in the pharmaceutical sector. They presently have a market worth of 28 billion USD and are expected to expand at a compound annual growth rate of at least 10% over the next five years. Peptide treatments based on highly restricted peptides are a novel class of medications that exhibit the therapeutic qualities of both small molecule and biologic drugs but are structurally distinct from both.
Equine-research provides scientists seeking the finest restricted peptide binders for their target protein with patented peptide technologies, peptide chemistry knowledge, and a proven track record in contract research and R&D partnerships. Equine-pay-for-service research’s approach for peptide discovery projects includes different success-based pricing structures.